SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-039642
Filing Date
2021-06-10
Accepted
2021-06-10 19:06:24
Documents
2
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3439
2 POA DOCUMENT poa.txt EX-24.3_991972 3042
  Complete submission text file 0001209191-21-039642.txt   7830
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Gujrathi Sheila (Reporting) CIK: 0001575202 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40475 | Film No.: 211009483

Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations